Table 4.

Outcome probabilities at five years (%)* for patients grouped according to IPSS cytogenetic risk categories (CGs) subdivided by remission-induction treatment outcome prior to the conditioning (CR1 vs. no CR1) and no treatment prior to the conditioning: “untreated” (RA/RARS versus others).

Table 4.